The efficacy and safety of ceftazidime/avibactam or polymyxin B based regimens for carbapenem-resistant Pseudomonas aeruginosa infection: a multicenter real-world and propensity score-matched study

Abstract

In conclusion, CAZ/AVI-based regimens demonstrated superior efficacy in clearing <i>CRPA</i> compared to PMB-based regimens. Furthermore, several factors associated with AKI and mortality in <i>CRPA</i>-infected patients were identified, highlighting the need for further research to optimize treatment strategies.